Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.48 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.45 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13475036 | 0.88 | FOLH1 (0.54) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12767763 | 0.87 | FOLH1 (0.61) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12147642 | 0.87 | FOLH1 (0.61) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12743524 | 0.87 | FOLH1 (0.59) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12972428 | 0.87 | FOLH1 (0.59) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL12147669 | 0.86 | MDK (0.50) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL14422376 | 0.84 | FOLH1 (0.52) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL8106640 | 0.82 | FOLH1 (0.54) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL8115912 | 0.81 | FOLH1 (0.61) | FOLH1PRSS1PRSS2PRSS3TPSAB1 | |
| SCHEMBL8121361 | 0.81 | FOLH1 (0.53) | FOLH1PRSS1PRSS2PRSS3TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632753-B2 | Multivalent constructs for therapeutic and diagnostic applications | BRACCO SUISSE SA (CH) | 2014-01-21 | — | — | US | disclosed |
| US-20110286929-A1 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | BRACCO INTERNATIONAL B.V. (NL) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110286929-A1 | MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | CD47, BCR, CD44 | FOLH1 84/4885PRSS1 3021/4885PRSS2 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.